Zachariae H
Department of Dermatology, Marselisborg Hospital, University of Aarhus, Denmark.
Br J Dermatol. 1990 Jun;122 Suppl 36:127-33. doi: 10.1111/j.1365-2133.1990.tb02890.x.
Methotrexate is by far the most widely used cytotoxic drug in psoriasis. Treatment requires normal kidney, liver and bone-marrow function, and pregnancy and alcohol abuse are absolute contraindications. Serious toxic reactions are recognized, but can be avoided if the drug is used correctly. The most important side-effects are haematopoietic and hepatotoxic. It is well established that long-term methotrexate can induce liver damage which, in a number of patients, may lead to fibrosis or cirrhosis. Recent studies have, however, documented that the methotrexate-induced liver cirrhosis is not aggressive. Interaction can occur with a number of drugs; serious problems in particular may arise with concomitant use of sulphonamides and salicylates. The recommended guidelines for methotrexate use in psoriasis should be followed and patients given clear instructions.
甲氨蝶呤是目前治疗银屑病最广泛使用的细胞毒性药物。治疗需要肾脏、肝脏和骨髓功能正常,妊娠和酗酒是绝对禁忌证。已知存在严重的毒性反应,但如果正确使用该药物,这些反应是可以避免的。最重要的副作用是血液系统和肝脏毒性。长期使用甲氨蝶呤可导致肝损伤,这在许多患者中可能会发展为纤维化或肝硬化,这一点已得到充分证实。然而,最近的研究表明,甲氨蝶呤引起的肝硬化并不具有侵袭性。甲氨蝶呤可与多种药物发生相互作用;特别是与磺胺类药物和水杨酸盐同时使用时,可能会出现严重问题。应遵循银屑病中甲氨蝶呤使用的推荐指南,并向患者提供明确的指导。